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Background: The aim of the present study was to evaluate the inﬂuence of organism type on the per-
formance of the synovial ﬂuid C-reactive protein (CRP) test.
Methods: We retrospectively reviewed the results of 21,422 synovial ﬂuid samples sent to one common
laboratory for the purpose of diagnostic testing for periprosthetic joint infection. Both a synovial ﬂuid
CRP result and a positive culture were present for 1789 submitted samples. The cultured organisms were
grouped by species, virulence, and gram type; and the median CRP level was determined for each group.
Results: The median synovial ﬂuid CRP level was signiﬁcantly lower for less-virulent organisms, when
compared to those organisms classiﬁed as virulent (15.10 mg/L vs 32.70 mg/L; P < .0001). Some less-
virulent species such as yeast and Staphylococcus epidermidis were associated with a 4-10 times lower
CRP response than those of virulent organisms such as Streptococcus agalactiae and Staphylococcus aureus
(P < .0001). Bacterial gram type had no inﬂuence on the median CRP result. The rate of false-negative CRP
values was 50.9% for yeast, 29.4% for S. epidermidis, 28.5% for all less-virulent organisms, and 11.6% for all
virulent organisms.
Conclusion: The CRP response appears to be highly dependent on the infecting organism and is more
likely to provide false-negative results in the setting of less-virulent organisms. Although the use of a CRP
level is an important part of the workup for periprosthetic joint infection, surgeons must be aware that
this protein may yield a false-negative result in the setting of less-virulent organisms.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).The C-reactive protein (CRP) test is arguably themost commonly
used test for periprosthetic joint infection (PJI) due to the simplicity
of a blood draw and its wide availability as a standard medical test.
Both the American Academy of Orthopaedic Surgeons [1] and the
Musculoskeletal Infection Society (MSIS) [2] recommend the use of
the serum CRP as part of an algorithm for diagnosing PJI.
However, there are some methodologic limitations and
concerns arising from the historical studies demonstrating the
utility of CRP in diagnosing PJI. First, most studies evaluating theclosed potential or pertinent
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Inc. This is an open access article uperformance of CRP were conducted before the MSIS deﬁnition
of PJI, resulting in variation in the deﬁnition of PJI in those
studies [3-7]. Second, most studies evaluating the performance of
CRP include a small group patients with PJI, resulting in large
conﬁdence intervals or no conﬁdence intervals associated with test
sensitivity [3,4,6,7].
Recently, the search for biomarkers of PJI has generated a sig-
niﬁcant number of publications, with most focusing on synovial
ﬂuid biomarkers [8-12]. Measurement of the synovial ﬂuid CRP has
been suggested by some to be more accurate than the serum
CRP [13-15] and by others to be equivalent to the serum CRP [16].
Nevertheless, study of the synovial ﬂuid CRP could provide the ﬁeld
with an enhanced understanding of this protein, speciﬁcally in
regard to its response to infection.
Recent studies which have used the MSIS deﬁnition of PJI
demonstrate that the sensitivity of serum CRP in detecting PJI is
closer to 80% [9,10], suggesting that the CRP test may fail to detectnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Study Groups.
Organism Category (N)
Gram type
Gram positive 1480
Gram negative 207
Yeast 57
Multiorganism 45
Virulence
Virulent 671
Less virulent 1073
Species with N > 20
Staphylococcus epidermidis 523
Staphylococcus aureus 362
Staphylococcus lugdunensis 117
Enterococcus faecalis 59
Yeast species 57
Pseudomonas aeruginosa 54
Streptococcus mitis 46
Streptococcus agalactiae 43
Staphylococcus caprae 32
Escherichia coli 29
Staphylococcus capitis 26
Staphylococcus hominis 22
Corynebacterium striatum 21
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has suggested that the serum CRP test may fail to detect some cases
of PJI caused by indolent organisms [17]. Understanding the limi-
tations of the CRP test could improve our ability of using this test
clinically. The aim of the present study was to evaluate the inﬂu-
ence of organism type on the performance of synovial ﬂuid CRP
test.
Methods
This study was approved by the institutional review board.
This retrospective review used deidentiﬁed testing results from
synovial ﬂuids aspirated from joint arthroplasties and submitted to
a common laboratory (Citrano Laboratories, subsidiary of CD
Diagnostics, Towson, MD) for the speciﬁed purpose of diagnostic
testing for PJI. From September 2013 to October 2015, a total of
21,421 synovial ﬂuid samples were submitted for testing at this
common laboratory. All tests performed in this study were per-
formed and reported by the same laboratory, which received
synovial ﬂuid samples by overnight delivery for diagnostic testing.
When restricting the review to those samples from a joint
replacement that had both a CRP test result and a positive culture
from the same synovial ﬂuid sample, we identiﬁed 1789 samples
that were included in this study. In this sample population, every
synovial ﬂuid with a positive culture also had a simultaneous
synovial ﬂuid CRP level available for study. These samples were
sent to the common laboratory by 792 physicians from 49 states in
the United States. Overall, 73.8% of samples were from a knee
replacement, 15.1% were from a hip replacement, 2.2% were from a
shoulder replacement, and 8.8% did not have a speciﬁed arthro-
plasty location.
The laboratory assay for synovial ﬂuid CRP used the Beckman
Olympus AU480 (Beckman Coulter Inc., Brea, CA) laboratory
chemistry analyzer. Previous studies evaluating the synovial ﬂuid
CRP test identiﬁed a range of optimal thresholds for PJI. For this
study, the threshold of 6.6mg/L was used, as it was a midrange
threshold in studies reviewed [13-16] and the result of one study's
receiver operating characteristic analysis [16]. However, the false-
negative rate of CRP for both virulent and less-virulent groups
was also calculated at a threshold of 3.0 mg/L, which is a low
threshold intended to maximize test sensitivity.
The synovial ﬂuid culture results evaluated for the study were
generated by BacT/ALERT FAN FA/FN culture bottles for recovery of
both aerobic and anaerobic organisms (Biomerieux, Durham, NC).
The organisms were identiﬁed and evaluated for susceptibilities
using the VITEK 2 ID/AST system (Biomerieux), a fully automated
system that provides rapid microbial identiﬁcation and suscepti-
bility testing. For sample submissions that speciﬁed a shoulder
arthroplasty, cultures were incubated in a supplemented broth to
allow for Propionibacterium acnes growth and held for 2 weeks.
The organisms identiﬁed by culture were classiﬁed by species,
virulence, and gram type. Organisms classiﬁed subjectively as
virulent included Staphylococcus aureus, Staphylococcus lugdu-
nensis, Streptococcus agalactiae, the Enterobacteriaceae, and the
nonfermenting gram-negative bacilli. All other organisms were
classiﬁed as less virulent. A total of 671 synovial ﬂuid samples in
this study resulted in the growth of a virulent organism and 1073
resulted in growth of a less-virulent organism. Forty-ﬁve ﬂuid
samples yielded multiorganism growth and were not included in
subgroup analysis. Among the 1744 samples yielding single or-
ganism growth, 1480 yielded a gram-positive organism, 207 yiel-
ded a gram-negative organism, and 57 yielded yeast. The organisms
isolated from the overall study group of ﬂuid samples was highly
typical of PJI, when considering the type and proportion of species
isolated (Table 1).Median CRP synovial ﬂuid levels were calculated for various
organism species, gram-type groups, as well as for virulent and
less-virulent groups. The median CRP values from each organism
grouping were compared for statistical signiﬁcance using the
2-tailed Mann-Whitney test for nonparametric data when
comparing 2 groups. When more than 2 groups were being
compared for a statistically signiﬁcant difference, a 1-way analysis
of variance test for nonparametric data was used, adjusting for
multiple comparisons with Dunn's test. These data are presented
along with interquartile ranges. When analyzing species-speciﬁc
results, only organisms that included sample N > 20 were
compared. A power analysis could not be completed, as no studies
have provided a basis by which to make educated assumptions
about the results.
Results
The median synovial ﬂuid CRP levels are highly dependent on
the infecting organism. Both the species and virulence of the or-
ganism have a very signiﬁcant inﬂuence on the associated median
synovial ﬂuid CRP levels.
When grouping organisms by species (Fig. 1), S. epidermidis and
yeast demonstrated lower associated synovial ﬂuid CRP levels
when compared with other organisms. Synovial ﬂuids yielding
S. epidermidis had a median synovial ﬂuid CRP (13.60 mg/L) that
was statistically signiﬁcantly lower than the median synovial
ﬂuid CRP levels associated with S. agalactiae (53.30 mg/L;
P < .0001), S. aureus (40.15 mg/L; P < .0001), Escherichia coli
(35.3 mg/L; P¼ .012), and Streptococcus mitis (30.2 mg/L; P¼ .0021).
Synovial ﬂuids yielding yeast growth had a median synovial ﬂuid
CRP (5.300 mg/L) that was statistically signiﬁcantly lower than the
median synovial ﬂuid CRP levels associated with S. agalactiae
(53.30 mg/L; P < .0001), S. aureus (40.15 mg/L; P < .0001), E. coli
(35.3 mg/L; P < .0001), and S. mitis (30.2 mg/L; P < .0001),
S. lugdunensis (21.60; P < .0001), S. epidermidis (13.60 mg/L;
P ¼ .0054), Enterococcus faecalis (18.8 mg/L; P ¼ .0017), and Pseu-
domonas aeruginosa (21.20 mg/L; P ¼ .0011).
Synovial ﬂuid samples yielding less-virulent organism growth
were associated with a lower mean synovial ﬂuid CRP level than
those yielding virulent organism growth (15.10mg/L vs 32.70mg/L;
P < .0001) (Fig. 2).
Fig. 3. The synovial ﬂuid CRP level does not vary by bacterial gram type but is lower in
the setting of infection by yeast. Each dot on the graph represents an individual pa-
tient's synovial ﬂuid sample. The black line marks the median CRP level. The blue lines
mark the interquartile range. The red dashed line marks the diagnostic threshold of 6.6
mg/L. Y-axis represented on a log scale.
Fig. 1. The synovial ﬂuid CRP level is highly dependent on the infecting organism. Each
dot on the graph represents an individual patient's synovial ﬂuid sample. The black
line marks the median CRP level. The blue lines mark the interquartile range. The red
dashed line marks the diagnostic threshold of 6.6 mg/L. Y-axis represented on a log
scale. CRP, C-reactive protein.
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median CRP levels from ﬂuids yielding gram-positive or gram-
negative bacteria (20.50 mg/L vs 18.50 mg/L; P ¼ .0743) (Fig. 3).
However, ﬂuids yielding the growth of yeast were associated
with statistically signiﬁcantly lower median synovial ﬂuid CRP
levels than both gram-positive and gram-negative bacterial
categories (5.300 mg/L vs 20.50 mg/L and 18.50 mg/L; both
P < .0001.)
When using a diagnostic threshold of 6.6 mg/L, the false-
negative rate of the CRP test was greater for synovial ﬂuids
yielding less virulent organism growth than those with virulent
organisms (28.5% vs 11.6%; P< .0001).When reducing the threshold
to 3 mg/L, a statistically signiﬁcant difference between the false-
negative rates remained (15.6% vs 5.5%; P < .0001). The highest
false negative rates were observed for S. epidermidis and yeast,
which demonstrated false-negative rates of 29.4% and 50.9%,
respectively at a CRP threshold of 6.6 mg/L.Fig. 2. The synovial ﬂuid CRP level is highly dependent on the infecting organism's
virulence. Each dot on the graph represents an individual patient's synovial ﬂuid
sample. The black line marks the median CRP level. The blue lines mark the inter-
quartile range. The red dashed line marks the diagnostic threshold of 6.6 mg/L. Y-axis
represented on a log scale.Conclusions
The CRP test has been recommended as one of the important
tests that should be used to diagnose PJI. The American Academy of
Orthopaedic Surgeons has recommended serology as a screening
test for PJI [1], suggesting that synovial ﬂuid aspirates should be
used as a secondary test when the serology is positive. However,
recent studies have suggested that the sensitivity of serum CRP at a
threshold of 10 mg/L is well below 90%, which questions the utility
of the serum CRP test as a reliable screening tool for PJI [9,10].
Unfortunately, previous reports on the high accuracy of the serum
CRP in diagnosing PJI experienced several ﬂaws, including varied
deﬁnitions of PJI, various CRP threshold values, and various patient
exclusion criteria [3-7]. An improved understanding of the physi-
ology of the CRP response is necessary to allow for optimal use in
the clinical setting of PJI.
Recently, several centers have reported on the clinical
performance of the synovial ﬂuid CRP level for the diagnosis of PJI
[13-16,18]. Although some centers suggest that the synovial ﬂuid
CRP is a better test for PJI than the serum test [13-15], others claim
that the synovial ﬂuid test equivalent to the serum test [16].
Nevertheless, the synovial ﬂuid CRP test provides an interesting
model for the study of the CRP response to PJI, given the fact that
the CRP test and culture are performed from the very same sample.
This guarantees the contemporaneous testing for CRP and culture
in the same patient and allows for accurate and complete extraction
of data from a large population of patients.
In this study, we found that the synovial ﬂuid CRP result is
highly dependent on the infecting organism.When our study group
of synovial ﬂuid samples with positive cultures is subdivided into
subgroups based on organism characteristics, it is clearly evident
that the CRP demonstrates a robust response to virulent organisms
but often fails to elevate in the setting of less-virulent organisms.
The most robust median CRP responses were observed for PJIs
caused by S. agalactiae (53.30 mg/L) and S. aureus (40.15 mg/L). The
weakest median CRP responses were observed is association with
PJIs caused by less-virulent organisms such as yeast (5.300 mg/L)
and S. epidermidis (13.60 mg/L).
In addition, the likelihood of a false-negative CRP response was
tripled in the synovial ﬂuid of patients with less-virulent infected
organisms as compared with virulent organisms. Although the
overall false-negative rate of the synovial ﬂuid CRP test is obviously
reduced at lower diagnostic threshold levels such as 3 mg/L, there
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(15.6%) in association with less-virulent organisms. Unfortunately,
lowering the threshold level of any diagnostic test invariably
increases the rate of false-positive testing and is detrimental to test
speciﬁcity.
The varied response of CRP to differing organisms as described
in the study is not surprising, considering the fact that the CRP
response is not unique to infectious processes but more generalized
to inﬂammation [19]. Therefore, the severity of inﬂammation and
the corresponding severity of the cytokine response would be
expected to have a great inﬂuence on the CRP response. This is in
contrast to biomarkers in the antimicrobial peptide family, which
are produced locally in the synovial ﬂuid in response to pathogenic
material. A recent study has demonstrated that the median alpha-
defensin concentration in the setting of PJI is equivalent regardless
of organism characteristics [20] and does not appear to vary based
on the severity of inﬂammation.
Our observation that the CRP test often fails to demonstrate
sufﬁcient elevation in response to PJIs caused by less-virulent or
indolent organisms likely explains the ﬁndings of recent studies,
which used the MSIS deﬁnition of infection and found the serum
CRP sensitivity to be approximately 80% [9,10]. In fact, one recent
study by McArthur et al. [17] from the Mayo Clinic found that false-
negative serum CRP results were most often associated with
indolent organisms. The idea that the CRP response to PJI may be
weak and possibly false negative in the setting of less-virulent
organisms is supported by this study of synovial ﬂuid CRP.
The main weakness of the study is the possibility of patient
misclassiﬁcation due to the lack of a full clinical data set to support
the diagnosis of PJI. It is true that false-positive cultures can occur
from synovial ﬂuid at a rate of 1%-5% [21,22]. It could be possible
that some of the false-negative CRP results in this study are actually
true-negative results with an associated false-positive culture. This
occurrence may be more likely in the setting of less-virulent
organism growth but would not cause the dramatic effect seen in
this study. On the other hand, this study could not include culture-
negative infections, which account for as much as 50% of PJIs in
some studies. One may suspect that diagnostic tests may be less
sensitive in a population of culture-negative PJIs [23]. We believe
that correcting this bias, which is not clinically feasible, would
likely not change our conclusions, but would actually alter the re-
sults in favor of our ﬁndings. A second weakness in our study is the
decision to choose the synovial ﬂuid CRP diagnostic threshold of 6.6
mg/L. We made this choice as it fell in the middle of the range
suggested by existing studies [13-16]. The purpose of providing
results at a lower, more sensitive, threshold of 3 mg/L in our results
section was to demonstrate the point that the exact threshold was
not critical to our conclusion that the CRP has a weaker response to
less-virulent organisms. Although the threshold of 3mg/Lmade the
synovial ﬂuid CRP a more sensitive test for PJI, it still did not
achieve the sensitivity of other biomarkers described in the
literature [8-10]. The main strength of this study was the large
volume of samples tested, allowing for the evaluation of CRP levels
among different subpopulations of organisms.
In conclusion, this study demonstrated a high dependence of
the CRP on the identity of the infecting organism and supports
recent research on the serum CRP suggesting the same. Althoughthe use of a CRP level is an important part of the workup for PJI,
surgeons must beware that this protein may yield a false-negative
result, especially in the setting of less-virulent organisms.References
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